Status:
COMPLETED
An Observational Study of Beta-Blocker Use in Patients With COPD and Acute MI
Lead Sponsor:
University of Minnesota
Collaborating Sponsors:
United States Department of Defense
University of Alabama at Birmingham
Conditions:
Pulmonary Disease, Chronic Obstructive
Eligibility:
All Genders
35+ years
Brief Summary
The study is a prospective, observational study of patients admitted to the BLOCK COPD network hospitals with acute AMI and Chronic Obstructive Pulmonary Disease (COPD) to determine the prevalence of ...
Detailed Description
Specific Aim 1. To determine the prevalence of COPD in patients admitted to the hospital with an acute myocardial infarction (AMI) and to characterize the phenotypic expression and severity of their u...
Eligibility Criteria
Inclusion
- Willing and able to provide informed consent (applicable for Option 1 and 2 only)
- Men and women age 35 or older
- Admitted to hospital from the Emergency Department or by hospital to hospital transfer with a primary diagnosis of AMI
- Undergo cardiac catheterization for AMI
- EMR-documented COPD
Exclusion
- Cognitive disorder that in the judgment of the investigator impairs understanding of the study objectives or assessments (applicable for Option 1 only)
- Vulnerable populations, including prisoners and pregnant women
Key Trial Info
Start Date :
June 28 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 2 2022
Estimated Enrollment :
584 Patients enrolled
Trial Details
Trial ID
NCT04717492
Start Date
June 28 2020
End Date
December 2 2022
Last Update
January 31 2025
Active Locations (24)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35294
2
University of California, San Francisco-Fresno
Fresno, California, United States, 93701
3
LA BioMed at Harbor-UCLA Medical Center
Los Angeles, California, United States, 90502
4
University of California at San Francisco
San Francisco, California, United States, 94143